Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-21 · accession 0001209191-22-020792 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-23 | 2022-03-21 | ANAB | Faga Daniel | Interim CEO, Dir | A - Grant | $0.00 | +887.0K | 887.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | A | A | 887,043 | $0.00 | 887,043 | D | — | — | (F1) Certain of the restricted stock units are subject to forfeiture to the Issuer if underlying vesting conditions are not met. |